Skip to search formSkip to main contentSkip to account menu

nisoxetine

Known as: 3-(2-methoxyphenoxy)-N-methyl-3-phenylpropylamine, 3-(o-methoxyphenoxy)-N-methyl-3-phenylpropylamine, N-methyl-gamma-(2-methylphenoxy)phenylpropanolamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Attention deficit/hyperactivity disorder (AD/HD) is characterized by significant difficulties of inattention and/or hyperactivity… 
2002
2002
Abstract. It has been suggested from a previous study in our laboratory that differences in the pharmacology of the species… 
1986
1986
SummaryThe specific (i.e., nisoxetine-sensitive) binding of3H-desipramine was studied in purified plasma membranes of PC-12 cells… 
1986
1986
The specific (i.e., nisoxetine-sensitive) binding of 3H-desipramine was studied in purified plasma membranes of PC-12 cells (rat… 
1985
1985
Some peripheral actions of the phenoxyphenylpropylamine, nisoxetine, have been compared with those of the tricyclic… 
1985
1985
Slices of the bovine and rabbit retina actively took up 14C-5HT from the incubation medium; the process was temperature- and Na… 
1977
1977
The effect of neuronal-uptake inhibitors on the guanethidine-induced inhibition of responses of rabbit vas deferens to transmural… 
1976
1976
: Fluoxetine prevents the loss of 5-hydroxytryptamine (5HT) uptake in synaptosomes of cerebral cortex after intraperitoneally… 
1976
1976
Nisoxetine, a potent and specific inhibitor of norepinephrine uptake, suppressed REM sleep in cats. Oral doses as small as 0.1 mg… 
1976
1976
Fluoxetine prevents the loss of 5-hydroxytryptamine (5HT) uptake in synaptosomes of cerebral cortex after intraperitoneally…